Visiting Israeli cannabis lab, Jamaican delegation eyes joint innovation

Jamaica's unique relationship with cannabis, coupled with Israel's expertise could lead to great innovation, Lumir Lab CEO said.

By
November 27, 2018 12:29
1 minute read.
Cannabis

Cannabis [Illustrative]. (photo credit: INIMAGE)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

A senior Jamaican delegation, including Agriculture and Industry Minister Audley Shaw, currently visiting Israel to deepen bilateral and business ties, used the opportunity to also expand its knowledge of the local cannabis industry.

The delegation visited Lumir Lab, a medical cannabis research lab located in the Biotechnology Park of the Hebrew University of Jerusalem’s Hadassah Ein Kerem campus. The delegation was welcomed by Lumir Lab CEO Yotam Hod and Professor Lumir Hanus, a 49-year veteran in cannabinoid research. Cannabinoids are the active ingredients in the cannabis plant that provide pain relief and are therefore used for medical purposes.

Jamaican delegation with CEO Yotam Hod at Lumir Lab (photo credit: Courtesy)

Hod said that cannabis was a significant part of Jamaica’s culture and tradition, and Jamaica recently developed a medical cannabis program that could greatly be enhanced by his company’s expertise.

“The vast knowledge accumulated in Jamaica as part of the use of cannabis in most households and the unique genetics of cannabis plants that found only in Jamaica, coupled with the distinctive scientific capabilities provided by Lumir Lab, create a unique collaboration that will lead to the development of advanced products,” Hod said.


Hanus, as one of the world’s most well-known researchers in the field, has written hundreds of articles on the subject and his discoveries form the basis for cannabis’s legitimacy as a medical treatment for a variety of diseases and symptoms around the world.

The delegation, which also included the director of the Cannabis Licensing Authority in Jamaica, the director of the Economic Development Authority, the president of the College of Agriculture and Science, as well as businessmen and directors of companies in the fields of agriculture and industry, expressed interest in the growing international research of the cannabis plant for the enormous economic and medical potential of expanding cannabis treatment to alternative medical fields.

Israel is considered a leader in global cannabis research and innovation. In 2017, medical cannabis companies received informal authorization from the government to start exporting locally grown cannabis in an industry that is projected to add billions of dollars to Israel’s economy.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

Basil
January 19, 2019
Bar-Ilan Univ. develops hybrid basil species resistant to epidemic disease

By ZACHARY KEYSER